Loading clinical trials...
Loading clinical trials...
Getting SMART for Pediatric Epilepsy (Sleep, Melatonin, and Research Trial, SMART)
The purpose of this study is to evaluate the effect of melatonin for improving sleep in pediatric epilepsy.
Sleep disturbances are more prevalent in children with epilepsy whose sleep can be disrupted by seizures occurring during the night and/or during the day. Melatonin is a naturally occurring hormone produced in the pineal which regulates sleep-wake cycles and facilitates quality sleep. Therefore, the purpose of this study is to evaluate the effect of melatonin for improving sleep in pediatric epilepsy.
Age
1 - 18 years
Sex
ALL
Healthy Volunteers
No
National Taiwan University Hospital
Taipei, Taiwan
Start Date
July 18, 2022
Primary Completion Date
January 3, 2025
Completion Date
January 3, 2025
Last Updated
August 29, 2025
147
ACTUAL participants
Melatonin
DRUG
Placebo
DRUG
Lead Sponsor
National Taiwan University Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06444126